A Human Ovarian Tumor & Liver Organ-on-Chip for Simultaneous and More Predictive Toxo-Efficacy Assays
In oncology, the poor success rate of clinical trials is becoming increasingly evident due to the weak predictability of preclinical assays, which either do not recapitulate the complexity of human tissues (i.e., in vitro tests) or reveal species-specific outcomes (i.e., animal testing). Therefore,...
Main Authors: | Arianna Fedi, Chiara Vitale, Marco Fato, Silvia Scaglione |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Bioengineering |
Subjects: | |
Online Access: | https://www.mdpi.com/2306-5354/10/2/270 |
Similar Items
-
A Microfluidic Device for Culturing an Encapsulated Ovarian Follicle
by: Aziz Ur Rehman Aziz, et al.
Published: (2017-11-01) -
Gut-on-a-Chip Research for Drug Development: Implications of Chip Design on Preclinical Oral Bioavailability or Intestinal Disease Studies
by: Joanne M. Donkers, et al.
Published: (2023-05-01) -
Versatile Vessel-on-a-Chip Platform for Studying Key Features of Blood Vascular Tumors
by: Marina Llenas, et al.
Published: (2021-06-01) -
Organ-on-a-chip: a more promising in vitro model
by: YANG Zhenli, XIA Yujia, LIU Yuqin
Published: (2024-09-01) -
Editorial: Medical and Industrial Applications of Microfluidic-Based Cell/Tissue Culture and Organs-on-a-Chip
by: Qasem Ramadan, et al.
Published: (2019-06-01)